# Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease

> **NCT00004293** · PHASE2 · UNKNOWN · sponsor: **National Center for Research Resources (NCRR)** · enrollment: 24 (—)

## Conditions studied

- Gaucher's Disease

## Interventions

- **DRUG:** glucocerebrosidase

## Key facts

- **NCT ID:** NCT00004293
- **Lead sponsor:** National Center for Research Resources (NCRR)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1999-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 24 (—)
- **Last updated:** 2005-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004293, "Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00004293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*